CompaniesClarassance

Clarassance

defunct
About

Defunct Company

Areas of Focus

Categories

Rebranded/RenamedBankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (3)
View all

Total Trials

3

As Lead Sponsor

3

As Collaborator

0

Total Enrollment

807

By Phase

PHASE1/PHASE2: 1

By Status

RECRUITING: 1UNKNOWN: 1COMPLETED: 1
Clinical Trials Pipeline3 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Today
Hover over trial bars to see details

Recent Trials

NCT05170815Lead Sponsor
Clariance ErYs Registry
N/ARecruiting
760 participants
Started: Jan 17, 2022 · Completed: Dec 31, 2025
NCT04584619Lead Sponsor
Idys™ TLIF 3DTi Post Market Clinical Follow-up
N/AUnknown
25 participants
Started: Oct 1, 2020 · Completed: Dec 31, 2023
NCT01473264Lead Sponsor
Safety, Pk and Anti-inflammatory Effects of CC10 Protein in Premature Infants With Respiratory Distress Syndrome (RDS)
PHASE1/PHASE2Completed
22 participants
Started: Jan 31, 2000 · Completed: Dec 31, 2003
Funding History (6)
D
Dec 27, 2016
Filing
D
Nov 18, 2015
Filing
D
Jun 17, 2014
Filing
D
Sep 18, 2012
Filing
D/A
Nov 10, 2011
Filing
D
Nov 10, 2010
Filing
Clarassance | Biotech Hunter | Biotech Hunter